RELATING TO REGISTRATION TO SELL MANUFACTURED HEMP PRODUCTS.
HB1111 creates a new registration framework for manufactured hemp product distributors and retailers in Hawaii. Beginning January 1, 2026, these businesses would be prohibited from selling or offering manufactured hemp products for sale unless they obtain a certificate of registration from the Department of Health. The bill sets a $50 application fee, a $50 annual renewal fee, and a $10 fee for duplicate certificates, and requires registrants to display the certificate at their physical location and, if selling online, on their website.
The bill also defines key terms such as “manufactured hemp product retailer,” “manufactured hemp product distributor,” “consumer,” “registry,” and “sale,” and clarifies that sales include in-person, online, telephonic, mail, catalog, and digital application transactions. It authorizes the Department of Health to maintain a public registry, inspect premises and records, sample or test products, and suspend or revoke registrations for noncompliance. The bill further amends enforcement provisions in chapter 328G and expands use of the Hawaii hemp processing special fund to support the new registration system.
HB1111 would amend chapter 328G, Hawaii Revised Statutes, by adding a new registration requirement for manufactured hemp product distributors and retailers and by updating related definitions and enforcement provisions. It would give the Department of Health new administrative authority over this segment of the hemp market, including fee collection, public listing of registrants, inspections, and suspension or revocation of certificates. The bill also broadens the stated purposes of the Hawaii hemp processing special fund to include regulating the sale of manufactured hemp products through this registration system.
The bill appears generally supportive of tighter oversight of manufactured hemp products, with its findings emphasizing consumer safety, noncompliant imported products, and the need for better enforcement. The available context shows no recorded votes or committee testimony, so there is no documented opposition or amendment debate in the provided materials. Overall, the measure is framed as a public-health and regulatory enforcement bill rather than a restriction on the hemp industry itself.
The main policy tension is between consumer protection and industry burden. Supporters would likely favor the Department of Health’s ability to identify noncompliant sellers, trace adverse events, and regulate a market described as difficult to police. Potential concerns for retailers, distributors, and carriers include the new registration fees, annual renewal obligations, inspection authority, and the requirement to comply before selling manufactured hemp products. The bill also draws a line excluding carriers from registration unless they actually sell the products, which helps limit the scope of regulation.